Tobin Schilke
Director of Finance/CFO at REVANCE THERAPEUTICS, INC.
Net worth: 633 871 $ as of 29/04/2024
Tobin Schilke active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 04/11/2018 | - |
| Director of Finance/CFO | 04/11/2018 | - |
Career history of Tobin Schilke
Former positions of Tobin Schilke
| Companies | Position | Start | End |
|---|---|---|---|
| ACHAOGEN | Director of Finance/CFO | 04/07/2016 | 30/09/2018 |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Director/Board Member | 31/08/2012 | 31/05/2016 |
| Director of Finance/CFO | 31/08/2012 | 31/05/2016 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/08/2012 | 31/07/2014 |
Training of Tobin Schilke
| Lafayette College | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Statistics
International
| United States | 7 |
| United Kingdom | 2 |
Operational
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Tobin Schilke
- Experience
